Zopiclone (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zopiclone" in English language version.

refsWebsite

Global rank English rank

91nih.gov

4^th place

57doi.org

2^nd place

23semanticscholar.org

11^th place

8^th place

4web.archive.org

1^st place

1in.gov.br

3,151^st place

5,932^nd place

1who.int

195^th place

302^nd place

1drugs.com

399^th place

333^rd place

1nice.org.uk

3,258^th place

2,666^th place

1worldcat.org

5^th place

1cmaj.ca

low place

1escholarship.org

1,523^rd place

976^th place

1evidence.nhs.uk

low place

1researchgate.net

120^th place

125^th place

1aspetjournals.org

6,663^rd place

5,792^nd place

1harvard.edu

18^th place

17^th place

1smw.ch

low place

aspetjournals.org

dmd.aspetjournals.org

Becquemont L, Mouajjah S, Escaffre O, Beaune P, Funck-Brentano C, Jaillon P (September 1999). "Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism". Drug Metabolism and Disposition. 27 (9): 1068–1073. PMID 10460808. Archived from the original on 2005-04-17. Retrieved 2008-12-16.

cmaj.ca

Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM (November 2003). "Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial". CMAJ. 169 (10): 1015–1020. PMC 236226. PMID 14609970.

doi.org

Van Der Kleijn E (1989). "Effects of zopiclone and temazepam on sleep, behaviour and mood during the day". European Journal of Clinical Pharmacology. 36 (3): 247–251. doi:10.1007/BF00558155. ISSN 0031-6970. PMID 2744064.
"What's wrong with prescribing hypnotics?". Drug and Therapeutics Bulletin. 42 (12): 89–93. December 2004. doi:10.1136/dtb.2004.421289. PMID 15587763. S2CID 40188442.
Touitou Y (July 2007). "[Sleep disorders and hypnotic agents: medical, social and economical impact]". Annales Pharmaceutiques Françaises (in French). 65 (4): 230–238. doi:10.1016/s0003-4509(07)90041-3. PMID 17652991.
Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, et al. (August 2014). "Pharmacological interventions for sleepiness and sleep disturbances caused by shift work". The Cochrane Database of Systematic Reviews. 2014 (8): CD009776. doi:10.1002/14651858.CD009776.pub2. PMC 10025070. PMID 25113164.
Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, et al. (June 2006). "Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial". JAMA. 295 (24): 2851–2858. doi:10.1001/jama.295.24.2851. PMID 16804151.
Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M (February 2004). "Psychological treatment for insomnia in the regulation of long-term hypnotic drug use". Health Technology Assessment. 8 (8): iii–iv, 1–68. doi:10.3310/hta8080. PMID 14960254.
Mets MA, Volkerts ER, Olivier B, Verster JC (August 2010). "Effect of hypnotic drugs on body balance and standing steadiness". Sleep Medicine Reviews. 14 (4): 259–267. doi:10.1016/j.smrv.2009.10.008. PMID 20171127.
Tada K, Sato Y, Sakai T, Ueda N, Kasamo K, Kojima T (1994). "Effects of zopiclone, triazolam, and nitrazepam on standing steadiness". Neuropsychobiology. 29 (1): 17–22. doi:10.1159/000119057. PMID 8127419.
Allain H, Bentué-Ferrer D, Tarral A, Gandon JM (July 2003). "Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo". European Journal of Clinical Pharmacology. 59 (3): 179–188. doi:10.1007/s00228-003-0591-5. PMID 12756510. S2CID 13440208.
Antai-Otong D (August 2006). "The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults". Perspectives in Psychiatric Care. 42 (3): 196–200. doi:10.1111/j.1744-6163.2006.00070.x. PMID 16916422.
Bain KT (June 2006). "Management of chronic insomnia in elderly persons". The American Journal of Geriatric Pharmacotherapy. 4 (2): 168–192. doi:10.1016/j.amjopharm.2006.06.006. PMID 16860264.
Parker G, Roberts CJ (September 1983). "Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease". British Journal of Clinical Pharmacology. 16 (3): 259–265. doi:10.1111/j.1365-2125.1983.tb02159.x. PMC 1428012. PMID 6626417.
Kripke DF (February 2016). "Mortality Risk of Hypnotics: Strengths and Limits of Evidence" (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222. S2CID 7946506.
Staner L, Ertlé S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, et al. (October 2005). "Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring". Psychopharmacology. 181 (4): 790–798. doi:10.1007/s00213-005-0082-8. PMID 16025317. S2CID 26351598.
Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, et al. (October 1998). "Association of road-traffic accidents with benzodiazepine use". Lancet. 352 (9137): 1331–1336. doi:10.1016/S0140-6736(98)04087-2. PMID 9802269. S2CID 40825194.
Rettig HC, de Haan P, Zuurmond WW, von Leeuwen L (December 1990). "Effects of hypnotics on sleep and psychomotor performance. A double-blind randomised study of lormetazepam, midazolam and zopiclone". Anaesthesia. 45 (12): 1079–1082. doi:10.1111/j.1365-2044.1990.tb14896.x. PMID 2278337. S2CID 36841164.
Billiard M, Besset A, de Lustrac C, Brissaud L (1987). "Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning". Sleep. 10 (Suppl 1): 27–34. doi:10.1093/sleep/10.suppl_1.27. PMID 3326113.
Mann K, Bauer H, Hiemke C, Röschke J, Wetzel H, Benkert O (August 1996). "Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion". Eur Neuropsychopharmacol. 6 (3): 163–168. doi:10.1016/0924-977X(96)00014-4. PMID 8880074. S2CID 25259646.
Wright NA, Belyavin A, Borland RG, Nicholson AN (June 1986). "Modulation of delta activity by hypnotics in middle-aged subjects: studies with a benzodiazepine (flurazepam) and a cyclopyrrolone (zopiclone)". Sleep. 9 (2): 348–352. doi:10.1093/sleep/9.2.348. PMID 3505734.
Kim YD, Zhuang HY, Tsutsumi M, Okabe A, Kurachi M, Kamikawa Y (October 1993). "Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women". Sleep. 16 (7): 655–661. doi:10.1093/sleep/16.7.655. PMID 8290860.
Kanno O, Watanabe H, Kazamatsuri H (March 1993). "Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition". Prog. Neuropsychopharmacol. Biol. Psychiatry. 17 (2): 229–239. doi:10.1016/0278-5846(93)90044-S. PMID 8430216. S2CID 54285586.
Noguchi H, Kitazumi K, Mori M, Shiba T (March 2004). "Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats". Journal of Pharmacological Sciences. 94 (3): 246–251. doi:10.1254/jphs.94.246. PMID 15037809.
Mannaert E, Tytgat J, Daenens P (November 1996). "Detection and quantification of the hypnotic zopiclone, connected with an uncommon case of drowning". Forensic Science International. 83 (1): 67–72. doi:10.1016/0379-0738(96)02018-X. PMID 8939015.
Buckley NA, Dawson AH, Whyte IM, O'Connell DL (January 1995). "Relative toxicity of benzodiazepines in overdose". BMJ. 310 (6974): 219–221. doi:10.1136/bmj.310.6974.219. PMC 2548618. PMID 7866122.
Meatherall RC (March 1997). "Zopiclone fatality in a hospitalized patient". Journal of Forensic Sciences. 42 (2): 340–343. doi:10.1520/JFS14125J. PMID 9068198.
Van Bocxlaer J, Meyer E, Clauwaert K, Lambert W, Piette M, De Leenheer A (1996). "Analysis of zopiclone (Imovane) in postmortem specimens by GC-MS and HPLC with diode-array detection". Journal of Analytical Toxicology. 20 (1): 52–54. doi:10.1093/jat/20.1.52. PMID 8837952.
Boniface PJ, Russell SG (1996). "Two cases of fatal zopiclone overdose". Journal of Analytical Toxicology. 20 (2): 131–133. doi:10.1093/jat/20.2.131. PMID 8868406.
Cienki JJ, Burkhart KK, Donovan JW (2005). "Zopiclone overdose responsive to flumazenil". Clinical Toxicology. 43 (5): 385–386. doi:10.1081/clt-200058944. PMID 16235515. S2CID 41701825.
Pounder DJ, Davies JI (May 1994). "Zopiclone poisoning: tissue distribution and potential for postmortem diffusion". Forensic Science International. 65 (3): 177–183. doi:10.1016/0379-0738(94)90273-9. PMID 8039775.
Carlsten A, Waern M, Holmgren P, Allebeck P (2003). "The role of benzodiazepines in elderly suicides". Scandinavian Journal of Public Health. 31 (3): 224–228. doi:10.1080/14034940210167966. PMID 12850977. S2CID 24102880.
Bramness JG, Arnestad M, Karinen R, Hilberg T (September 2001). "Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma". Journal of Forensic Sciences. 46 (5): 1247–1249. doi:10.1520/JFS15131J. PMID 11569575.
Caille G, du Souich P, Spenard J, Lacasse Y, Vezina M (April 1984). "Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers". Biopharmaceutics & Drug Disposition. 5 (2): 117–125. doi:10.1002/bdd.2510050205. PMID 6743780.
Mattila ME, Mattila MJ, Nuotto E (April 1992). "Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects". Pharmacology & Toxicology. 70 (4): 286–289. doi:10.1111/j.1600-0773.1992.tb00473.x. PMID 1351673.
Koski A, Ojanperä I, Vuori E (May 2003). "Interaction of alcohol and drugs in fatal poisonings". Human & Experimental Toxicology. 22 (5): 281–287. doi:10.1191/0960327103ht324oa. PMID 12774892. S2CID 37777007.
Aranko K, Luurila H, Backman JT, Neuvonen PJ, Olkkola KT (October 1994). "The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone". British Journal of Clinical Pharmacology. 38 (4): 363–367. doi:10.1111/j.1365-2125.1994.tb04367.x. PMC 1364781. PMID 7833227.
Jalava KM, Olkkola KT, Neuvonen PJ (1996). "Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone". European Journal of Clinical Pharmacology. 51 (3–4): 331–334. doi:10.1007/s002280050207. PMID 9010708. S2CID 20916689.
Villikka K, Kivistö KT, Lamberg TS, Kantola T, Neuvonen PJ (May 1997). "Concentrations and effects of zopiclone are greatly reduced by rifampicin". British Journal of Clinical Pharmacology. 43 (5): 471–474. doi:10.1046/j.1365-2125.1997.00579.x. PMC 2042775. PMID 9159561.
Alderman CP, Gebauer MG, Gilbert AL, Condon JT (November 2001). "Possible interaction of zopiclone and nefazodone". The Annals of Pharmacotherapy. 35 (11): 1378–1380. doi:10.1345/aph.1A074. PMID 11724087. S2CID 38894701.^{[permanent dead link]}
Röschke J, Mann K, Aldenhoff JB, Benkert O (March 1994). "Functional properties of the brain during sleep under subchronic zopiclone administration in man". European Neuropsychopharmacology. 4 (1): 21–30. doi:10.1016/0924-977X(94)90311-5. PMID 8204993. S2CID 40503805.
Petroski RE, Pomeroy JE, Das R, Bowman H, Yang W, Chen AP, et al. (April 2006). "Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors". The Journal of Pharmacology and Experimental Therapeutics. 317 (1): 369–377. doi:10.1124/jpet.105.096701. PMID 16399882. S2CID 46510829.
Atack JR (August 2003). "Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site". Current Drug Targets. CNS and Neurological Disorders. 2 (4): 213–232. doi:10.2174/1568007033482841. PMID 12871032.
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (July 2004). "Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis". Human Psychopharmacology. 19 (5): 305–322. doi:10.1002/hup.594. PMID 15252823. S2CID 10888200.
Blanchard JC, Julou L (March 1983). "Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum". Journal of Neurochemistry. 40 (3): 601–607. doi:10.1111/j.1471-4159.1983.tb08023.x. PMID 6298365. S2CID 35732735.
Skerritt JH, Johnston GA (May 1983). "Enhancement of GABA binding by benzodiazepines and related anxiolytics". European Journal of Pharmacology. 89 (3–4): 193–198. doi:10.1016/0014-2999(83)90494-6. PMID 6135616.
De Deyn PP, Macdonald RL (September 1988). "Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture". British Journal of Pharmacology. 95 (1): 109–120. doi:10.1111/j.1476-5381.1988.tb16554.x. PMC 1854132. PMID 2905900.
Julou L, Bardone MC, Blanchard JC, Garret C, Stutzmann JM (1983). "Pharmacological studies on zopiclone". Pharmacology. 27 (Suppl 2): 46–58. doi:10.1159/000137911. PMID 6142468.
Blanchard JC, Boireau A, Julou L (1983). "Brain receptors and zopiclone". Pharmacology. 27 (Suppl 2): 59–69. doi:10.1159/000137912. PMID 6322210.
Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH (August 2004). "Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization". Journal of Mass Spectrometry. 39 (8): 856–72. Bibcode:2004JMSp...39..856K. doi:10.1002/jms.599. PMID 15329838.
Gustavsen I, Al-Sammurraie M, Mørland J, Bramness JG (May 2009). "Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers". Accident Analysis and Prevention. 41 (3): 462–6. doi:10.1016/j.aap.2009.01.011. PMID 19393793.
Blaschke G, Hempel G, Müller WE (1993). "Preparative and analytical separation of the zopiclone enantiomers and determination of their affinity to the benzodiazepine receptor binding site". Chirality. 5 (6): 419–421. doi:10.1002/chir.530050605. PMID 8398600.
Hoffmann F, Pfannkuche M, Glaeske G (January 2008). "[High usage of zolpidem and zopiclone. Cross-sectional study using claims data]". Der Nervenarzt (in German). 79 (1): 67–72. doi:10.1007/s00115-007-2280-6. PMID 17457554. S2CID 31103719.
Ströhle A, Antonijevic IA, Steiger A, Sonntag A (January 1999). "[Dependency of non-benzodiazepine hypnotics. Two case reports]". Der Nervenarzt (in German). 70 (1): 72–75. doi:10.1007/s001150050403. PMID 10087521. S2CID 42630879.
Sikdar S (July 1998). "Physical dependence on zopiclone. Prescribing this drug to addicts may give rise to iatrogenic drug misuse". BMJ. 317 (7151): 146. doi:10.1136/bmj.317.7151.146. PMC 1113504. PMID 9657802.
Kuntze MF, Bullinger AH, Mueller-Spahn F (September 2002). "Excessive use of zopiclone: a case report" (PDF). Swiss Medical Weekly. 132 (35–36): 523. doi:10.4414/smw.2002.10074. PMID 12506335. S2CID 33400840. Archived from the original (PDF) on 2016-03-03. Retrieved 2008-12-18.
Jones AW, Holmgren A, Kugelberg FC (April 2007). "Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results". Therapeutic Drug Monitoring. 29 (2): 248–260. doi:10.1097/FTD.0b013e31803d3c04. PMID 17417081. S2CID 25511804.
Menzin J, Lang KM, Levy P, Levy E (January 2001). "A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France". PharmacoEconomics. 19 (1): 69–78. doi:10.2165/00019053-200119010-00005. PMID 11252547. S2CID 45013069.
Kintz P, Villain M, Ludes B (April 2004). "Testing for the undetectable in drug-facilitated sexual assault using hair analyzed by tandem mass spectrometry as evidence". Therapeutic Drug Monitoring. 26 (2): 211–214. doi:10.1097/00007691-200404000-00022. PMID 15228167. S2CID 46445345.

drugs.com

"Zopiclone consumer information from". Drugs.com. Retrieved 2013-06-06.

escholarship.org

Kripke DF (February 2016). "Mortality Risk of Hypnotics: Strengths and Limits of Evidence" (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222. S2CID 7946506.

evidence.nhs.uk

"Zopiclone", British National Formulary, National Institute for Health and Care Excellence, 19 September 2016, archived from the original on 9 October 2016, retrieved 2 October 2016

harvard.edu

ui.adsabs.harvard.edu

Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH (August 2004). "Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization". Journal of Mass Spectrometry. 39 (8): 856–72. Bibcode:2004JMSp...39..856K. doi:10.1002/jms.599. PMID 15329838.

in.gov.br

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

nice.org.uk

"Chapter 3 - The technologies, section 3.4", Clinical need and practice - Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia, National Institute for Health and Care Excellence (NICE), 28 April 2004, Technology appraisal guidance [TA77], This guidance will be reviewed if there is new evidence. Current as of 8 June 2023

nih.gov

pubmed.ncbi.nlm.nih.gov

Van Der Kleijn E (1989). "Effects of zopiclone and temazepam on sleep, behaviour and mood during the day". European Journal of Clinical Pharmacology. 36 (3): 247–251. doi:10.1007/BF00558155. ISSN 0031-6970. PMID 2744064.
"What's wrong with prescribing hypnotics?". Drug and Therapeutics Bulletin. 42 (12): 89–93. December 2004. doi:10.1136/dtb.2004.421289. PMID 15587763. S2CID 40188442.
Touitou Y (July 2007). "[Sleep disorders and hypnotic agents: medical, social and economical impact]". Annales Pharmaceutiques Françaises (in French). 65 (4): 230–238. doi:10.1016/s0003-4509(07)90041-3. PMID 17652991.
Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, et al. (August 2014). "Pharmacological interventions for sleepiness and sleep disturbances caused by shift work". The Cochrane Database of Systematic Reviews. 2014 (8): CD009776. doi:10.1002/14651858.CD009776.pub2. PMC 10025070. PMID 25113164.
"Cognitive therapy superior to zopiclone for insomnia". The Journal of Family Practice. 55 (10): 845. October 2006. PMID 17089469.
Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM (November 2003). "Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial". CMAJ. 169 (10): 1015–1020. PMC 236226. PMID 14609970.
Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, et al. (June 2006). "Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial". JAMA. 295 (24): 2851–2858. doi:10.1001/jama.295.24.2851. PMID 16804151.
Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M (February 2004). "Psychological treatment for insomnia in the regulation of long-term hypnotic drug use". Health Technology Assessment. 8 (8): iii–iv, 1–68. doi:10.3310/hta8080. PMID 14960254.
Mets MA, Volkerts ER, Olivier B, Verster JC (August 2010). "Effect of hypnotic drugs on body balance and standing steadiness". Sleep Medicine Reviews. 14 (4): 259–267. doi:10.1016/j.smrv.2009.10.008. PMID 20171127.
Tada K, Sato Y, Sakai T, Ueda N, Kasamo K, Kojima T (1994). "Effects of zopiclone, triazolam, and nitrazepam on standing steadiness". Neuropsychobiology. 29 (1): 17–22. doi:10.1159/000119057. PMID 8127419.
Allain H, Bentué-Ferrer D, Tarral A, Gandon JM (July 2003). "Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo". European Journal of Clinical Pharmacology. 59 (3): 179–188. doi:10.1007/s00228-003-0591-5. PMID 12756510. S2CID 13440208.
Antai-Otong D (August 2006). "The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults". Perspectives in Psychiatric Care. 42 (3): 196–200. doi:10.1111/j.1744-6163.2006.00070.x. PMID 16916422.
Bain KT (June 2006). "Management of chronic insomnia in elderly persons". The American Journal of Geriatric Pharmacotherapy. 4 (2): 168–192. doi:10.1016/j.amjopharm.2006.06.006. PMID 16860264.
Parker G, Roberts CJ (September 1983). "Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease". British Journal of Clinical Pharmacology. 16 (3): 259–265. doi:10.1111/j.1365-2125.1983.tb02159.x. PMC 1428012. PMID 6626417.
Kripke DF (February 2016). "Mortality Risk of Hypnotics: Strengths and Limits of Evidence" (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222. S2CID 7946506.
Staner L, Ertlé S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, et al. (October 2005). "Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring". Psychopharmacology. 181 (4): 790–798. doi:10.1007/s00213-005-0082-8. PMID 16025317. S2CID 26351598.
Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, et al. (October 1998). "Association of road-traffic accidents with benzodiazepine use". Lancet. 352 (9137): 1331–1336. doi:10.1016/S0140-6736(98)04087-2. PMID 9802269. S2CID 40825194.
Yasui M, Kato A, Kanemasa T, Murata S, Nishitomi K, Koike K, et al. (June 2005). "[Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes]". Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 25 (3): 143–151. PMID 16045197.
Rettig HC, de Haan P, Zuurmond WW, von Leeuwen L (December 1990). "Effects of hypnotics on sleep and psychomotor performance. A double-blind randomised study of lormetazepam, midazolam and zopiclone". Anaesthesia. 45 (12): 1079–1082. doi:10.1111/j.1365-2044.1990.tb14896.x. PMID 2278337. S2CID 36841164.
Lader M, Denney SC (1982). "A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers". International Pharmacopsychiatry. 17 (Suppl 2): 98–108. PMID 7188379.
Billiard M, Besset A, de Lustrac C, Brissaud L (1987). "Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning". Sleep. 10 (Suppl 1): 27–34. doi:10.1093/sleep/10.suppl_1.27. PMID 3326113.
Paul MA, Gray G, Kenny G, Pigeau RA (December 2003). "Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance". Aviation, Space, and Environmental Medicine. 74 (12). Aerospace Medical Association: 1263–1270. PMID 14692469.
Trachsel L, Dijk DJ, Brunner DP, Klene C, Borbély AA (February 1990). "Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule". Neuropsychopharmacology. 3 (1): 11–18. PMID 2306331.
Mann K, Bauer H, Hiemke C, Röschke J, Wetzel H, Benkert O (August 1996). "Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion". Eur Neuropsychopharmacol. 6 (3): 163–168. doi:10.1016/0924-977X(96)00014-4. PMID 8880074. S2CID 25259646.
Wright NA, Belyavin A, Borland RG, Nicholson AN (June 1986). "Modulation of delta activity by hypnotics in middle-aged subjects: studies with a benzodiazepine (flurazepam) and a cyclopyrrolone (zopiclone)". Sleep. 9 (2): 348–352. doi:10.1093/sleep/9.2.348. PMID 3505734.
Kim YD, Zhuang HY, Tsutsumi M, Okabe A, Kurachi M, Kamikawa Y (October 1993). "Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women". Sleep. 16 (7): 655–661. doi:10.1093/sleep/16.7.655. PMID 8290860.
Kanno O, Watanabe H, Kazamatsuri H (March 1993). "Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition". Prog. Neuropsychopharmacol. Biol. Psychiatry. 17 (2): 229–239. doi:10.1016/0278-5846(93)90044-S. PMID 8430216. S2CID 54285586.
Noguchi H, Kitazumi K, Mori M, Shiba T (March 2004). "Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats". Journal of Pharmacological Sciences. 94 (3): 246–251. doi:10.1254/jphs.94.246. PMID 15037809.
Mannaert E, Tytgat J, Daenens P (November 1996). "Detection and quantification of the hypnotic zopiclone, connected with an uncommon case of drowning". Forensic Science International. 83 (1): 67–72. doi:10.1016/0379-0738(96)02018-X. PMID 8939015.
Buckley NA, Dawson AH, Whyte IM, O'Connell DL (January 1995). "Relative toxicity of benzodiazepines in overdose". BMJ. 310 (6974): 219–221. doi:10.1136/bmj.310.6974.219. PMC 2548618. PMID 7866122.
Meatherall RC (March 1997). "Zopiclone fatality in a hospitalized patient". Journal of Forensic Sciences. 42 (2): 340–343. doi:10.1520/JFS14125J. PMID 9068198.
Van Bocxlaer J, Meyer E, Clauwaert K, Lambert W, Piette M, De Leenheer A (1996). "Analysis of zopiclone (Imovane) in postmortem specimens by GC-MS and HPLC with diode-array detection". Journal of Analytical Toxicology. 20 (1): 52–54. doi:10.1093/jat/20.1.52. PMID 8837952.
Yamazaki M, Terada M, Mitsukuni Y, Yoshimura M (August 1998). "[An autopsy case of poisoning by neuropsychopharmaceuticals including zopiclone]". Nihon Hoigaku Zasshi = the Japanese Journal of Legal Medicine (in Japanese). 52 (4): 245–252. PMID 9893443.
Boniface PJ, Russell SG (1996). "Two cases of fatal zopiclone overdose". Journal of Analytical Toxicology. 20 (2): 131–133. doi:10.1093/jat/20.2.131. PMID 8868406.
Cienki JJ, Burkhart KK, Donovan JW (2005). "Zopiclone overdose responsive to flumazenil". Clinical Toxicology. 43 (5): 385–386. doi:10.1081/clt-200058944. PMID 16235515. S2CID 41701825.
Pounder DJ, Davies JI (May 1994). "Zopiclone poisoning: tissue distribution and potential for postmortem diffusion". Forensic Science International. 65 (3): 177–183. doi:10.1016/0379-0738(94)90273-9. PMID 8039775.
Regouby Y, Delomez G, Tisserant A (1990). "[First-degree heart block caused by voluntary zopiclone poisoning]". Therapie (in French). 45 (2): 162. PMID 2353332.
Regouby Y, Delomez G, Tisserant A (1989). "[Auriculo-ventricular block during voluntary poisoning with zopiclone]". Therapie (in French). 44 (5): 379–380. PMID 2814922.
Carlsten A, Waern M, Holmgren P, Allebeck P (2003). "The role of benzodiazepines in elderly suicides". Scandinavian Journal of Public Health. 31 (3): 224–228. doi:10.1080/14034940210167966. PMID 12850977. S2CID 24102880.
Harry P (April 1997). "[Acute poisoning by new psychotropic drugs]". La Revue du Praticien. 47 (7): 731–735. PMID 9183949.
Bramness JG, Arnestad M, Karinen R, Hilberg T (September 2001). "Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma". Journal of Forensic Sciences. 46 (5): 1247–1249. doi:10.1520/JFS15131J. PMID 11569575.
Caille G, du Souich P, Spenard J, Lacasse Y, Vezina M (April 1984). "Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers". Biopharmaceutics & Drug Disposition. 5 (2): 117–125. doi:10.1002/bdd.2510050205. PMID 6743780.
Mattila ME, Mattila MJ, Nuotto E (April 1992). "Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects". Pharmacology & Toxicology. 70 (4): 286–289. doi:10.1111/j.1600-0773.1992.tb00473.x. PMID 1351673.
Kuitunen T, Mattila MJ, Seppala T (April 1990). "Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol". International Clinical Psychopharmacology. 5 (Suppl 2): 115–130. PMID 2201724.
Koski A, Ojanperä I, Vuori E (May 2003). "Interaction of alcohol and drugs in fatal poisonings". Human & Experimental Toxicology. 22 (5): 281–287. doi:10.1191/0960327103ht324oa. PMID 12774892. S2CID 37777007.
Aranko K, Luurila H, Backman JT, Neuvonen PJ, Olkkola KT (October 1994). "The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone". British Journal of Clinical Pharmacology. 38 (4): 363–367. doi:10.1111/j.1365-2125.1994.tb04367.x. PMC 1364781. PMID 7833227.
Jalava KM, Olkkola KT, Neuvonen PJ (1996). "Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone". European Journal of Clinical Pharmacology. 51 (3–4): 331–334. doi:10.1007/s002280050207. PMID 9010708. S2CID 20916689.
Villikka K, Kivistö KT, Lamberg TS, Kantola T, Neuvonen PJ (May 1997). "Concentrations and effects of zopiclone are greatly reduced by rifampicin". British Journal of Clinical Pharmacology. 43 (5): 471–474. doi:10.1046/j.1365-2125.1997.00579.x. PMC 2042775. PMID 9159561.
Becquemont L, Mouajjah S, Escaffre O, Beaune P, Funck-Brentano C, Jaillon P (September 1999). "Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism". Drug Metabolism and Disposition. 27 (9): 1068–1073. PMID 10460808. Archived from the original on 2005-04-17. Retrieved 2008-12-16.
Alderman CP, Gebauer MG, Gilbert AL, Condon JT (November 2001). "Possible interaction of zopiclone and nefazodone". The Annals of Pharmacotherapy. 35 (11): 1378–1380. doi:10.1345/aph.1A074. PMID 11724087. S2CID 38894701.^{[permanent dead link]}
Röschke J, Mann K, Aldenhoff JB, Benkert O (March 1994). "Functional properties of the brain during sleep under subchronic zopiclone administration in man". European Neuropsychopharmacology. 4 (1): 21–30. doi:10.1016/0924-977X(94)90311-5. PMID 8204993. S2CID 40503805.
Petroski RE, Pomeroy JE, Das R, Bowman H, Yang W, Chen AP, et al. (April 2006). "Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors". The Journal of Pharmacology and Experimental Therapeutics. 317 (1): 369–377. doi:10.1124/jpet.105.096701. PMID 16399882. S2CID 46510829.
Atack JR (August 2003). "Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site". Current Drug Targets. CNS and Neurological Disorders. 2 (4): 213–232. doi:10.2174/1568007033482841. PMID 12871032.
Liu HJ, Sato K, Shih HC, Shibuya T, Kawamoto H, Kitagawa H (March 1985). "Pharmacologic studies of the central action of zopiclone: effects on locomotor activity and brain monoamines in rats". International Journal of Clinical Pharmacology, Therapy, and Toxicology. 23 (3): 121–128. PMID 2581904.
Sato K, Hong YL, Yang MS, Shibuya T, Kawamoto H, Kitagawa H (April 1985). "Pharmacologic studies of central actions of zopiclone: influence on brain monoamines in rats under stressful condition". International Journal of Clinical Pharmacology, Therapy, and Toxicology. 23 (4): 204–210. PMID 2860074.
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (July 2004). "Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis". Human Psychopharmacology. 19 (5): 305–322. doi:10.1002/hup.594. PMID 15252823. S2CID 10888200.
Blanchard JC, Julou L (March 1983). "Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum". Journal of Neurochemistry. 40 (3): 601–607. doi:10.1111/j.1471-4159.1983.tb08023.x. PMID 6298365. S2CID 35732735.
Skerritt JH, Johnston GA (May 1983). "Enhancement of GABA binding by benzodiazepines and related anxiolytics". European Journal of Pharmacology. 89 (3–4): 193–198. doi:10.1016/0014-2999(83)90494-6. PMID 6135616.
De Deyn PP, Macdonald RL (September 1988). "Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture". British Journal of Pharmacology. 95 (1): 109–120. doi:10.1111/j.1476-5381.1988.tb16554.x. PMC 1854132. PMID 2905900.
Julou L, Bardone MC, Blanchard JC, Garret C, Stutzmann JM (1983). "Pharmacological studies on zopiclone". Pharmacology. 27 (Suppl 2): 46–58. doi:10.1159/000137911. PMID 6142468.
Blanchard JC, Boireau A, Julou L (1983). "Brain receptors and zopiclone". Pharmacology. 27 (Suppl 2): 59–69. doi:10.1159/000137912. PMID 6322210.
Gaillot J, Heusse D, Hougton GW, Marc Aurele J, Dreyfus JF (1982). "Pharmacokinetics and metabolism of zopiclone". International Pharmacopsychiatry. 17 (Suppl 2): 76–91. PMID 7188377.
Viron B, De Meyer M, Le Liboux A, Frydman A, Maillard F, Mignon F, et al. (April 1990). "Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure". International Clinical Psychopharmacology. 5 (Suppl 2): 95–104. PMID 2387982.
Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH (August 2004). "Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization". Journal of Mass Spectrometry. 39 (8): 856–72. Bibcode:2004JMSp...39..856K. doi:10.1002/jms.599. PMID 15329838.
Gustavsen I, Al-Sammurraie M, Mørland J, Bramness JG (May 2009). "Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers". Accident Analysis and Prevention. 41 (3): 462–6. doi:10.1016/j.aap.2009.01.011. PMID 19393793.
Holbrook AM, Crowther R, Lotter A, Cheng C, King D (January 2000). "Meta-analysis of benzodiazepine use in the treatment of insomnia". CMAJ. 162 (2): 225–233. PMC 1232276. PMID 10674059.
Blaschke G, Hempel G, Müller WE (1993). "Preparative and analytical separation of the zopiclone enantiomers and determination of their affinity to the benzodiazepine receptor binding site". Chirality. 5 (6): 419–421. doi:10.1002/chir.530050605. PMID 8398600.
Fernandez C, Maradeix V, Gimenez F, Thuillier A, Farinotti R (November 1993). "Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers". Drug Metabolism and Disposition. 21 (6): 1125–1128. PMID 7905394.
Cimolai N (December 2007). "Zopiclone: is it a pharmacologic agent for abuse?". Canadian Family Physician. 53 (12): 2124–2129. PMC 2231551. PMID 18077750.
Griffiths RR, Johnson MW (2005). "Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds". The Journal of Clinical Psychiatry. 66 (Suppl 9): 31–41. PMID 16336040.
Hoffmann F, Pfannkuche M, Glaeske G (January 2008). "[High usage of zolpidem and zopiclone. Cross-sectional study using claims data]". Der Nervenarzt (in German). 79 (1): 67–72. doi:10.1007/s00115-007-2280-6. PMID 17457554. S2CID 31103719.
Bramness JG, Olsen H (May 1998). "[Adverse effects of zopiclone]". Tidsskrift for den Norske Laegeforening (in Norwegian). 118 (13): 2029–2032. PMID 9656789.
Ströhle A, Antonijevic IA, Steiger A, Sonntag A (January 1999). "[Dependency of non-benzodiazepine hypnotics. Two case reports]". Der Nervenarzt (in German). 70 (1): 72–75. doi:10.1007/s001150050403. PMID 10087521. S2CID 42630879.
Sikdar S (July 1998). "Physical dependence on zopiclone. Prescribing this drug to addicts may give rise to iatrogenic drug misuse". BMJ. 317 (7151): 146. doi:10.1136/bmj.317.7151.146. PMC 1113504. PMID 9657802.
Kuntze MF, Bullinger AH, Mueller-Spahn F (September 2002). "Excessive use of zopiclone: a case report" (PDF). Swiss Medical Weekly. 132 (35–36): 523. doi:10.4414/smw.2002.10074. PMID 12506335. S2CID 33400840. Archived from the original (PDF) on 2016-03-03. Retrieved 2008-12-18.
Jones AW, Holmgren A, Kugelberg FC (April 2007). "Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results". Therapeutic Drug Monitoring. 29 (2): 248–260. doi:10.1097/FTD.0b013e31803d3c04. PMID 17417081. S2CID 25511804.
Bramness JG, Skurtveit S, Mørland J (August 1999). "[Detection of zopiclone in many drivers--a sign of misuse or abuse]". Tidsskrift for den Norske Laegeforening (in Norwegian). 119 (19): 2820–2821. PMID 10494203.
Menzin J, Lang KM, Levy P, Levy E (January 2001). "A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France". PharmacoEconomics. 19 (1): 69–78. doi:10.2165/00019053-200119010-00005. PMID 11252547. S2CID 45013069.
Kintz P, Villain M, Ludes B (April 2004). "Testing for the undetectable in drug-facilitated sexual assault using hair analyzed by tandem mass spectrometry as evidence". Therapeutic Drug Monitoring. 26 (2): 211–214. doi:10.1097/00007691-200404000-00022. PMID 15228167. S2CID 46445345.
Yanagita T (1982). "Dependence potential of zopiclone studied in monkeys". International Pharmacopsychiatry. 17 (2): 216–227. PMID 6892368.

ncbi.nlm.nih.gov

Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, et al. (August 2014). "Pharmacological interventions for sleepiness and sleep disturbances caused by shift work". The Cochrane Database of Systematic Reviews. 2014 (8): CD009776. doi:10.1002/14651858.CD009776.pub2. PMC 10025070. PMID 25113164.
Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM (November 2003). "Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial". CMAJ. 169 (10): 1015–1020. PMC 236226. PMID 14609970.
Parker G, Roberts CJ (September 1983). "Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease". British Journal of Clinical Pharmacology. 16 (3): 259–265. doi:10.1111/j.1365-2125.1983.tb02159.x. PMC 1428012. PMID 6626417.
Buckley NA, Dawson AH, Whyte IM, O'Connell DL (January 1995). "Relative toxicity of benzodiazepines in overdose". BMJ. 310 (6974): 219–221. doi:10.1136/bmj.310.6974.219. PMC 2548618. PMID 7866122.
Aranko K, Luurila H, Backman JT, Neuvonen PJ, Olkkola KT (October 1994). "The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone". British Journal of Clinical Pharmacology. 38 (4): 363–367. doi:10.1111/j.1365-2125.1994.tb04367.x. PMC 1364781. PMID 7833227.
Villikka K, Kivistö KT, Lamberg TS, Kantola T, Neuvonen PJ (May 1997). "Concentrations and effects of zopiclone are greatly reduced by rifampicin". British Journal of Clinical Pharmacology. 43 (5): 471–474. doi:10.1046/j.1365-2125.1997.00579.x. PMC 2042775. PMID 9159561.
De Deyn PP, Macdonald RL (September 1988). "Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture". British Journal of Pharmacology. 95 (1): 109–120. doi:10.1111/j.1476-5381.1988.tb16554.x. PMC 1854132. PMID 2905900.
Holbrook AM, Crowther R, Lotter A, Cheng C, King D (January 2000). "Meta-analysis of benzodiazepine use in the treatment of insomnia". CMAJ. 162 (2): 225–233. PMC 1232276. PMID 10674059.
Cimolai N (December 2007). "Zopiclone: is it a pharmacologic agent for abuse?". Canadian Family Physician. 53 (12): 2124–2129. PMC 2231551. PMID 18077750.
Sikdar S (July 1998). "Physical dependence on zopiclone. Prescribing this drug to addicts may give rise to iatrogenic drug misuse". BMJ. 317 (7151): 146. doi:10.1136/bmj.317.7151.146. PMC 1113504. PMID 9657802.

pubchem.ncbi.nlm.nih.gov

"Zopiclone". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine. Retrieved 11 June 2018.

researchgate.net

Paul MA, Gray G, Kenny G, Pigeau RA (December 2003). "Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance". Aviation, Space, and Environmental Medicine. 74 (12). Aerospace Medical Association: 1263–1270. PMID 14692469.

semanticscholar.org

api.semanticscholar.org

"What's wrong with prescribing hypnotics?". Drug and Therapeutics Bulletin. 42 (12): 89–93. December 2004. doi:10.1136/dtb.2004.421289. PMID 15587763. S2CID 40188442.
Allain H, Bentué-Ferrer D, Tarral A, Gandon JM (July 2003). "Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo". European Journal of Clinical Pharmacology. 59 (3): 179–188. doi:10.1007/s00228-003-0591-5. PMID 12756510. S2CID 13440208.
Kripke DF (February 2016). "Mortality Risk of Hypnotics: Strengths and Limits of Evidence" (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222. S2CID 7946506.
Staner L, Ertlé S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, et al. (October 2005). "Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring". Psychopharmacology. 181 (4): 790–798. doi:10.1007/s00213-005-0082-8. PMID 16025317. S2CID 26351598.
Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, et al. (October 1998). "Association of road-traffic accidents with benzodiazepine use". Lancet. 352 (9137): 1331–1336. doi:10.1016/S0140-6736(98)04087-2. PMID 9802269. S2CID 40825194.
Rettig HC, de Haan P, Zuurmond WW, von Leeuwen L (December 1990). "Effects of hypnotics on sleep and psychomotor performance. A double-blind randomised study of lormetazepam, midazolam and zopiclone". Anaesthesia. 45 (12): 1079–1082. doi:10.1111/j.1365-2044.1990.tb14896.x. PMID 2278337. S2CID 36841164.
Mann K, Bauer H, Hiemke C, Röschke J, Wetzel H, Benkert O (August 1996). "Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion". Eur Neuropsychopharmacol. 6 (3): 163–168. doi:10.1016/0924-977X(96)00014-4. PMID 8880074. S2CID 25259646.
Kanno O, Watanabe H, Kazamatsuri H (March 1993). "Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition". Prog. Neuropsychopharmacol. Biol. Psychiatry. 17 (2): 229–239. doi:10.1016/0278-5846(93)90044-S. PMID 8430216. S2CID 54285586.
Cienki JJ, Burkhart KK, Donovan JW (2005). "Zopiclone overdose responsive to flumazenil". Clinical Toxicology. 43 (5): 385–386. doi:10.1081/clt-200058944. PMID 16235515. S2CID 41701825.
Carlsten A, Waern M, Holmgren P, Allebeck P (2003). "The role of benzodiazepines in elderly suicides". Scandinavian Journal of Public Health. 31 (3): 224–228. doi:10.1080/14034940210167966. PMID 12850977. S2CID 24102880.
Koski A, Ojanperä I, Vuori E (May 2003). "Interaction of alcohol and drugs in fatal poisonings". Human & Experimental Toxicology. 22 (5): 281–287. doi:10.1191/0960327103ht324oa. PMID 12774892. S2CID 37777007.
Jalava KM, Olkkola KT, Neuvonen PJ (1996). "Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone". European Journal of Clinical Pharmacology. 51 (3–4): 331–334. doi:10.1007/s002280050207. PMID 9010708. S2CID 20916689.
Alderman CP, Gebauer MG, Gilbert AL, Condon JT (November 2001). "Possible interaction of zopiclone and nefazodone". The Annals of Pharmacotherapy. 35 (11): 1378–1380. doi:10.1345/aph.1A074. PMID 11724087. S2CID 38894701.^{[permanent dead link]}
Röschke J, Mann K, Aldenhoff JB, Benkert O (March 1994). "Functional properties of the brain during sleep under subchronic zopiclone administration in man". European Neuropsychopharmacology. 4 (1): 21–30. doi:10.1016/0924-977X(94)90311-5. PMID 8204993. S2CID 40503805.
Petroski RE, Pomeroy JE, Das R, Bowman H, Yang W, Chen AP, et al. (April 2006). "Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors". The Journal of Pharmacology and Experimental Therapeutics. 317 (1): 369–377. doi:10.1124/jpet.105.096701. PMID 16399882. S2CID 46510829.
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (July 2004). "Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis". Human Psychopharmacology. 19 (5): 305–322. doi:10.1002/hup.594. PMID 15252823. S2CID 10888200.
Blanchard JC, Julou L (March 1983). "Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum". Journal of Neurochemistry. 40 (3): 601–607. doi:10.1111/j.1471-4159.1983.tb08023.x. PMID 6298365. S2CID 35732735.
Hoffmann F, Pfannkuche M, Glaeske G (January 2008). "[High usage of zolpidem and zopiclone. Cross-sectional study using claims data]". Der Nervenarzt (in German). 79 (1): 67–72. doi:10.1007/s00115-007-2280-6. PMID 17457554. S2CID 31103719.
Ströhle A, Antonijevic IA, Steiger A, Sonntag A (January 1999). "[Dependency of non-benzodiazepine hypnotics. Two case reports]". Der Nervenarzt (in German). 70 (1): 72–75. doi:10.1007/s001150050403. PMID 10087521. S2CID 42630879.
Kuntze MF, Bullinger AH, Mueller-Spahn F (September 2002). "Excessive use of zopiclone: a case report" (PDF). Swiss Medical Weekly. 132 (35–36): 523. doi:10.4414/smw.2002.10074. PMID 12506335. S2CID 33400840. Archived from the original (PDF) on 2016-03-03. Retrieved 2008-12-18.
Jones AW, Holmgren A, Kugelberg FC (April 2007). "Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results". Therapeutic Drug Monitoring. 29 (2): 248–260. doi:10.1097/FTD.0b013e31803d3c04. PMID 17417081. S2CID 25511804.
Menzin J, Lang KM, Levy P, Levy E (January 2001). "A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France". PharmacoEconomics. 19 (1): 69–78. doi:10.2165/00019053-200119010-00005. PMID 11252547. S2CID 45013069.
Kintz P, Villain M, Ludes B (April 2004). "Testing for the undetectable in drug-facilitated sexual assault using hair analyzed by tandem mass spectrometry as evidence". Therapeutic Drug Monitoring. 26 (2): 211–214. doi:10.1097/00007691-200404000-00022. PMID 15228167. S2CID 46445345.

smw.ch

Kuntze MF, Bullinger AH, Mueller-Spahn F (September 2002). "Excessive use of zopiclone: a case report" (PDF). Swiss Medical Weekly. 132 (35–36): 523. doi:10.4414/smw.2002.10074. PMID 12506335. S2CID 33400840. Archived from the original (PDF) on 2016-03-03. Retrieved 2008-12-18.

web.archive.org

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
"Zopiclone", British National Formulary, National Institute for Health and Care Excellence, 19 September 2016, archived from the original on 9 October 2016, retrieved 2 October 2016
Becquemont L, Mouajjah S, Escaffre O, Beaune P, Funck-Brentano C, Jaillon P (September 1999). "Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism". Drug Metabolism and Disposition. 27 (9): 1068–1073. PMID 10460808. Archived from the original on 2005-04-17. Retrieved 2008-12-16.
Kuntze MF, Bullinger AH, Mueller-Spahn F (September 2002). "Excessive use of zopiclone: a case report" (PDF). Swiss Medical Weekly. 132 (35–36): 523. doi:10.4414/smw.2002.10074. PMID 12506335. S2CID 33400840. Archived from the original (PDF) on 2016-03-03. Retrieved 2008-12-18.

who.int

"Assessment of Zopiclone" (PDF). World Health Organization. Essential Medicines and Health Products. World Health Organization. 2006. p. 9 (Section 5. Pharmacokinetics). Retrieved 5 December 2015.

worldcat.org

Van Der Kleijn E (1989). "Effects of zopiclone and temazepam on sleep, behaviour and mood during the day". European Journal of Clinical Pharmacology. 36 (3): 247–251. doi:10.1007/BF00558155. ISSN 0031-6970. PMID 2744064.